Article info

Download PDFPDF
Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma

Authors

  1. Correspondence to Dr Bita Esmaeli, Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; besmaeli{at}mdanderson.org
View Full Text

Citation

Goldfarb JA, Ferrarotto R, Gross N, et al
Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma

Publication history

  • Received July 18, 2021
  • Accepted September 27, 2021
  • First published October 8, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.